Perspective Therapeutics Inc Quick Ratio (CATX) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Perspective Therapeutics Inc   (NYSEAMER: CATX)

Perspective Therapeutics Inc 's Quick Ratio

CATX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Perspective Therapeutics Inc 's Cash & cash equivalent grew by 72.63 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Perspective Therapeutics Inc 's Quick Ratio to 12.8, above Perspective Therapeutics Inc average Quick Ratio.

Within Medical Equipment & Supplies industry 8 other companies have achieved higher Quick Ratio than Perspective Therapeutics Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 549, from total ranking in the first quarter 2026 at 955.

Explain Quick Ratio?
How much Cash & cash equivalents CATX´s has?
What are CATX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CATX Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 181.41 % 148.33 % 52.91 % -26.74 % 22.39 %
Y / Y Cash & cash equivalent Change 144.13 % 27.98 % -47.74 % -34.99 % -34.59 %
Quick Ratio MRQ 12.8 8.6 5.05 8.45 14.75
CATX's Total Ranking # 549 # 955 # 604 # 355 # 332
Seq. Current Liabilities Change 16.06 % 9.79 % 39.1 % 58.77 % 2.42 %
Seq. Cash & cash equivalent Change 72.63 % 87.19 % -16.88 % -9.1 % -9.51 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 9
Healthcare Sector # 128
Overall Market # 369


Quick Ratio Statistics
High Average Low
35.44 10.52 0.47
(Dec 31 2021)   (Dec 31 2023)




Financial Statements
Perspective Therapeutics Inc 's Current Liabilities $ 37 Millions Visit CATX's Balance sheet
Perspective Therapeutics Inc 's Cash & cash equivalent $ 468 Millions Visit CATX's Balance sheet
Source of CATX's Sales Visit CATX's Sales by Geography


Cumulative Perspective Therapeutics Inc 's Quick Ratio

CATX's Quick Ratio for the trailling 12 Months

CATX Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 61.69 % 33.6 % 4.1 % -10.72 % 37.37 %
Y / Y Cash & cash equivalent TTM Growth 11.54 % -25.54 % -29.08 % 13.83 % 89.34 %
Quick Ratio TTM 9.01 8.33 9.63 13.14 13.07
Total Ranking TTM # 3421 # 3440 # 2578 # 2544 # 2532
Seq. Current Liabilities TTM Growth 25.12 % 25.09 % 15.26 % -10.37 % 3.39 %
Seq. Cash & cash equivalent TTM Growth 35.34 % 8.2 % -15.48 % -9.88 % -9.65 %

Quick ratio ranking by company, industry and sector >> Back to CATX Financial Strength Comparisons >> Go to Compare CATX Quick Ratio to its Competitors

On the trailing twelve months basis CATX Cash & cash equivalent more than doubled by 144.13 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Perspective Therapeutics Inc 's Quick Ratio to 9.01, Quick Ratio remained below CATX average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 190 other companies have achieved higher Quick Ratio than Perspective Therapeutics Inc . While Quick Ratio overall ranking has improved so far to 3421, from total ranking during the twelve months ending first quarter 2026 at 3440.

Explain Quick Ratio?
How much Cash & cash equivalents CATX´s has?
What are CATX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 191
Healthcare Sector # 852
Within the Market # 3421


trailing twelve months Quick Ratio Statistics
High Average Low
34.74 10.33 1.42
(Dec 31 2021)   (Dec 31 2020)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Microbot Medical Inc   34.10 $ 132.596  Millions$ 3.888  Millions
Global Innovative Platforms Inc.  31.35 $ 0.244  Millions$ 0.008  Millions
Anteris Technologies Global Corp   14.02 $ 257.385  Millions$ 18.360  Millions
Heartflow Inc   13.95 $ 615.238  Millions$ 44.088  Millions
Ceribell Inc   13.13 $ 225.898  Millions$ 17.200  Millions
Perspective Therapeutics Inc   12.80 $ 467.708  Millions$ 36.544  Millions
Lemaitre Vascular Inc   12.57 $ 376.240  Millions$ 29.935  Millions
Mobia Medical Inc   12.24 $ 177.090  Millions$ 14.472  Millions
Envveno Medical Corporation  11.39 $ 21.486  Millions$ 1.887  Millions
Pulse Biosciences Inc   9.26 $ 101.620  Millions$ 10.978  Millions
Orchestra Biomed Holdings Inc   8.16 $ 109.963  Millions$ 13.471  Millions
Biolife Solutions Inc   8.11 $ 113.100  Millions$ 13.947  Millions
Bone Biologics Corporation  7.87 $ 4.032  Millions$ 0.512  Millions
Beyond Air Inc   7.68 $ 26.340  Millions$ 3.428  Millions
Talkspace Inc   7.62 $ 90.998  Millions$ 11.937  Millions
Safe Pro Group Inc   7.24 $ 10.231  Millions$ 1.413  Millions
Delcath Systems Inc   7.22 $ 95.902  Millions$ 13.279  Millions
Streamex Corp   7.16 $ 18.586  Millions$ 2.595  Millions
Endra Life Sciences Inc  7.04 $ 5.540  Millions$ 0.787  Millions
Iradimed Corporation  6.45 $ 59.080  Millions$ 9.164  Millions
Orasure Technologies Inc  6.39 $ 160.582  Millions$ 25.119  Millions
Alpha Pro Tech Ltd   5.94 $ 18.901  Millions$ 3.180  Millions
Si bone inc   5.89 $ 141.519  Millions$ 24.042  Millions
Dexcom Inc   5.84 $ 1,107.000  Millions$ 189.500  Millions
Cvrx inc   5.78 $ 64.586  Millions$ 11.177  Millions
Carlsmed Inc   5.67 $ 70.244  Millions$ 12.397  Millions
Profound Medical Corp   5.24 $ 38.271  Millions$ 7.304  Millions
Rxsight Inc   5.03 $ 404.247  Millions$ 80.444  Millions
Transmedics Group Inc   4.81 $ 472.675  Millions$ 98.283  Millions
Aethlon Medical Inc   4.76 $ 4.934  Millions$ 1.036  Millions

Date modified: 2026-09-12T06:10:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.